Canada’s progress towards ending the HIV epidemic

Download the alternative format
(PDF format, 88 KB, 1 page)

Organization: Public Health Agency of Canada

Published: 2024-07-18

Canada has committed to meeting the global targets for HIV testing and treatment.Reference 1 By 2025 the global targets areReference 2:

There were an estimated 65,270 people living with HIV (PLHIV) in Canada at the end of 2022.

Among PLHIV:

HIV disproportionately affects certain people, populations and communities.

The estimated HIV prevalence in 2022 among these populations was:

Canada’s progress towards meeting the 95-95-95 targets in 2022Reference 6:

1 in 10 PLHIV did not know their status

The COVID-19 pandemic reduced the demand for and access to services, and impacted Canada’s progress towards meeting the 95-95-95 targets.

Continued efforts to provide culturally competent care and support will help Canada recover from the impact of the pandemic.

The HIV care continuum targets for females living with HIV were lower compared to males.

Males: 48,368 PLHIV

Females: 16,544 PLHIV

An estimated 1,848 new infections occurred in Canada in 2022. This is a 15% increase from the estimate for 2020 (1,610).

5 people were infected each day

New infections occur more frequently in some populations compared to the general population.

The estimated 2022 HIV incidence rates (per 100,000 people) were:

Interventions to prevent the spread of HIV

References / Notes

Reference 1

Government of Canada’s sexually transmitted and blood-borne infections action plan 2024 - 2030 https://www.canada.ca/en/public-health/services/publications/diseases-conditions/sexually-transmitted-blood-borne-infections-action-plan-2024-2030.html

Return to reference 1

Reference 2

Global health sector strategies on, respectively, HIV, viral hepatitis and sexually transmitted infections for the period 2022 - 2030 https://www.who.int/teams/global-hiv-hepatitis-and-stis-programmes/strategies/global-health-sector-strategies

Return to reference 2

Reference 3

HIV prevalence among PWID: estimated number of people who have ever injected drugs living with HIV (8,573) / national estimated population size (revised and unpublished) of people who have ever injected drugs in 2021 (388,400). Incidence: calculated using estimated number of new infections among HIV-negative people who had injected drugs in the last 12 months.

Return to reference 3

Reference 4

HIV prevalence among gbMSM: estimated number of gbMSM living with HIV (33,183) / national Identity-or-Behaviour gbMSM population size estimate in 2020 (669,613). HIV incidence among sexually active gbMSM: calculated using estimated number of new infections among HIV-negative gbMSM who reported anal sex in the past 6 to 12 months.

Return to reference 4

Reference 5

Sorge JT, Colyer S, Cox J, Kroch AE, Lachowsky NJ, Popovic N, Yang Q. Estimation of the population size of gay, bisexual and other men who have sex with men in Canada, 2020. Can Commun Dis Rep 2023;49(11/12):465–76. https://doi.org/10.14745/ccdr.v49i1112a02

Return to reference 5

Reference 6

These estimates replace all previous estimates published by the Public Health Agency of Canada concerning progress towards HIV elimination in Canada. Updated data were available, and improvements were incorporated into the methods. Revisions to the methodology mean that the 2022 estimates should not be compared directly with previously published estimates.

Return to reference 6

Reference 7

Preventing HIV transmission: Undetectable = Untransmittable https://www.canada.ca/en/public-health/services/publications/diseases-conditions/preventing-hiv-transmission-undetectable-equals-untransmittable-communication-tips-health-professionals.html

Return to reference 7

Reference 8

HIV factsheet: Biomedical prevention of HIV – PrEP and PEP https://www.canada.ca/en/public-health/services/publications/diseases-conditions/hiv-factsheet-biomedical-prevention-prep-pep.html

Return to reference 8

Page details

Date modified: